Clinical Trial Update: Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD) [Phase 2]

View source ↗

Summary

Phase 2 trial updating safety of furosemide in premature infants at risk of bronchopulmonary dysplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Bronchopulmonary Dysplasia | Phase 2 | Status: COMPLETED | Results posted: 2021-12-28